Kromek Group plc (AIM:KMK)

London flag London · Delayed Price · Currency is GBP · Price in GBX
8.78
-0.02 (-0.23%)
Jul 7, 2026, 4:24 PM GMT
Market Cap57.65M +44.3%
Revenue (ttm)37.84M +136.8%
Net Income12.50M
EPS0.02
Shares Out 655.14M
PE Ratio4.55
Forward PE23.40
Dividendn/a
Ex-Dividend Daten/a
Volume1,028,662
Open8.92
Previous Close8.80
Day's Range8.60 - 9.08
52-Week Range4.70 - 13.00
Beta1.34
AnalystsStrong Buy
Price Target22.50 (+156.26%)
Earnings DateJul 24, 2026

About Kromek Group

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator t... [Read more]

Industry Hardware, Equipment & Parts
Sector Technology
Founded 2003
Employees 162
Stock Exchange London Stock Exchange AIM
Ticker Symbol KMK
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for KMK stock is "Strong Buy." The 12-month stock price target is 23p, which is an increase of 156.26% from the latest price.

Price Target
23p
(156.26% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Kromek Group Earnings release: H2 2026

Kromek Group released its H2 2026 earnings on May 12, 2026, summarizing the period's financial results.

2 months ago - Filings

Half Year 2026 Kromek Group PLC Earnings Presentation Transcript

Half Year 2026 Kromek Group PLC Earnings Presentation Transcript

5 months ago - GuruFocus

Kromek Group Earnings Call Transcript: H1 2026

CZT detector adoption in medical imaging is accelerating, with Kromek positioned to supply 40% of a $400M market by 2030. Profitability has been achieved, growth is underpinned by major contracts, and future expansion will be funded through debt and structured supply agreements.

5 months ago - Transcripts

Kromek Group Quarterly report: H1 2026

Kromek Group has published its H1 2026 quarterly earnings report on January 26, 2026.

5 months ago - Filings

Kromek Group Earnings Call Transcript: H2 2025

Profitability and revenue growth were driven by the Siemens deal, strong contract wins, and expanding CBRN and biosecurity segments. Gross margin rose to 81%, and the company targets £60M revenue and 30% EBITDA margin by 2030, with continued year-on-year profit expected.

9 months ago - Transcripts

Kromek Group Annual report: H2 2025

Kromek Group has published its H2 2025 annual report on October 3, 2025.

9 months ago - Filings

Kromek secures £1.7m UK government contract for nuclear detection

The UK-based radiation detection specialist, has secured a £1.7m contract under the UK Government’s Radiological Nuclear Detection Framework.

1 year ago - The Armchair Trader

SMALL CAP MOVERS: Kromek eyes profitability after £30m Siemens Healthineers deal

Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.

1 year ago - This is Money

AIM Market Roundup: Mosman Oil, Sancus Lending, Kromek

Mosman Oil, Sancus Lending, Kromek, Futura Medical, Petards are today's biggest risers and fallers on London's AIM market

1 year ago - The Armchair Trader